Avanos Medical AVNS PM&R — Reportable segment operating income (loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's pm&r — reportable segment operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's PM&R — reportable segment operating income (loss)?
- Avanos Medical (AVNS) reported PM&R — reportable segment operating income (loss) of -$1.8M in Q1 2026.
- How has Avanos Medical's PM&R — reportable segment operating income (loss) changed year-over-year?
- Avanos Medical's PM&R — reportable segment operating income (loss) decreased by 1000.0% year-over-year, from $200K to -$1.8M.
- What is the long-term trend for Avanos Medical's PM&R — reportable segment operating income (loss)?
- Over 2 years (2023 to 2025), Avanos Medical's PM&R — reportable segment operating income (loss) has grown at a 57.7% compound annual growth rate (CAGR), from -$3.7M to $9.2M.
- What does PM&R — reportable segment operating income (loss) mean?
- Calculated as the segment's net sales minus its direct operating expenses, including cost of goods sold and operating overheads. It serves as the primary measure of the segment's core profitability and operational performance before corporate-level allocations.